Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells (Q41259289)
Jump to navigation
Jump to search
scientific article published on September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells |
scientific article published on September 2016 |
Statements
1 reference
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells (English)
1 reference
1 reference
David G Maloney
1 reference
Cameron J Turtle
1 reference
Laïla-Aïcha Hanafi
1 reference
Carolina Berger
1 reference
Barbara Pender
1 reference
Emily Robinson
1 reference
Reed Hawkins
1 reference
Colette Chaney
1 reference
Sindhu Cherian
1 reference
Xueyan Chen
1 reference
Lorinda Soma
1 reference
Brent Wood
1 reference
Daniel Li
1 reference
Shelly Heimfeld
1 reference
Stanley R Riddell
1 reference
1 September 2016
1 reference
1 reference
8
1 reference
355
1 reference
355ra116
1 reference
Identifiers
1 reference
1 reference
1 reference